Product review · Updated September 30, 2026
DERMA E Peptide Moisturizer review: the denominator behind 100%
An elasticity-result headline, its six-week footnote and a separate line-level clinical statement examined without inventing trial methods.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
DERMA E's Advanced Peptides & Flora-Collagen Moisturizer has a striking result headline: 100% saw improved skin elasticity. The number does not describe the amount of peptide in the moisturizer, nor does it say elasticity increased by 100%. Its meaning depends on the people counted, the assessment used and the study described by the footnote.
The official product, clinical-summary and product-data records were captured September 30, 2026. They provide enough detail to examine the headline's limits, but not a full clinical report. The complete returned formula names other peptides and no copper. We did not try the moisturizer, inspect a package or independently verify a result in participants.
In this article
The named moisturizer and data record match
The product page describes an advanced Multi-Peptide Complex and Flora-Collagen Booster within the moisturizer. Its official data record identifies Advanced Peptides & Flora-Collagen Moisturizer under the skin-restore-peptide-moisturizer handle. This gives useful identity context for the claim being reviewed. Product page and official product data.
The data also contains manufacturer image-alt text describing cosmetic cream. We did not independently view that image or handle the product; Cream is the disclosed product grouping, not a sensory finding. The public-record comparison offers background for matching a headline to the exact product document before trying to compare its number with another seller's claim.
100% is a reported share, not an active amount
The displayed statement says 100% saw improved skin elasticity. That phrasing reports a share with a result; it does not quantify the size of each improvement. It also cannot serve as a concentration for the Multi-Peptide Complex, Flora-Collagen Booster or any individual ingredient. Elasticity headline.
The selected record does not give the participant denominator or state the assessment procedure behind saw improved. We therefore do not label it a consumer-perception survey, instrument result or clinician assessment without further support. The study-endpoint guide explains why an endpoint's method matters alongside its reported percentage. A complete response share still leaves substantial questions if the underlying count and measurement remain unavailable.
The product footnote should not be repaired by guesswork
The moisturizer's footnote describes results from a regimen-independent single-use clinical trial after six weeks. That is the wording returned in the retained record. Its compressed description does not explain the detailed protocol, comparison group or analysis. We preserve the six-week study context without converting it into instructions or inventing what single use meant to the researchers. Product footnote.
The encoded official product data repeats the claim and footnote. It is useful corroboration of the manufacturer's text, but a repeated sentence is not an additional trial. The PTR evidence review is linked as another topic for study-summary reading, without importing its methods or participant groups into this moisturizer's unresolved report.
A second official clinical page has a broader scope
The retained clinical-results page supplies a footnote about efficacy results from independent six-week clinical studies on the Skin Restore line. That is a meaningful second official source because it identifies the brand's wider clinical-summary scope. It does not disclose a separate denominator or complete product-specific report for the moisturizer's 100% headline. Clinical-summary footnote.
Line-level studies cannot silently become multiple replicated trials of this exact formula. Nor does the adjective independent explain who assessed participants, what control was used or which endpoints were selected. The firmness-claims discussion provides background for reading an outcome label without supplying the missing methods. This review keeps the two official summaries distinct.
The complete formula is an other-peptide comparator
The captured ingredient declaration includes Palmitoyl Tripeptide-38 and Acetyl Hexapeptide-8. It names no copper ingredient. Panthenol, vitamin-related entries and many other components also appear in the list, so the record concerns a finished mixture rather than an isolated peptide experiment. Complete product declaration.
We do not infer an individual peptide amount from that list or assign the elasticity headline solely to either peptide. The Le Mieux serum review offers a separate declaration-reading topic. Linking these other-peptide reviews does not establish identical formulas, an equivalent result or a clinical ranking against copper products. Their captured lists each require their own interpretation.
Clinical language does not remove the unanswered methods
The product page calls the moisturizer clinically proven and describes elasticity, bounce and the appearance of fine lines. The clinical-summary footnote and official data preserve that marketing context, but none of the selected records supplies the full study needed to independently evaluate the result. Product claim, line-level summary and data record.
Missing details include the counted population, assessment method, comparator and size of change. Those are different omissions, and they cannot be resolved by restating 100%. We neither confirm the advertised result nor conclude the product failed. The available summaries support an attributed claim with explicit methodological limits rather than a replicated numerical finding.
The denominator is the central evidence question
The official records identify the moisturizer, its complete captured declaration and the wording attached to its elasticity headline. They leave the number of participants and the definition of improvement unresolved. Those limits are material because a percentage of people reporting or showing change is not the magnitude of change experienced by every person. Retained product record.
The review would need a product-matched report to move beyond that distinction. Until then, 100% remains the manufacturer's result summary, with its six-week context and incomplete methods preserved. The absence of copper in the reviewed declaration is simply the comparator's scope. It supplies no reason to call the moisturizer inferior, predict a personal response or choose a routine.
Sources behind this reading
- DERMA E: Advanced Peptides & Flora-Collagen Moisturizer ↗Moisturizer identity, full non-copper list and narrowly disclosed clinical-results footnote · Checked September 30, 2026
- DERMA E: Official Skin Restore product data record ↗Exact product identity and manufacturer image alt identifying cosmetic cream; image not independently viewed · Checked September 30, 2026
- DERMA E: Advanced Peptides Moisturizer clinicals page ↗Separate narrowly extracted Skin Restore-line footnote; no full trial · Checked September 30, 2026